Symptoms of posttraumatic stress disorder and adjustment disorder in hematological cancer patients with different treatment regimes

References

• Mehnert A, Brähler E, Faller H, et al. Four-Week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol. 2014;32(31):3540–3546. doi: 10.1200/JCO.2014.56.0086.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160–174. doi: 10.1016/S1470-2045(11)70002-X.
   PubMed Web of Science ®Google Scholar
• Abbey G, Thompson SBN, Hickish T, et al. A meta-analysis of prevalence rates and moderating factors for cancer-related post-traumatic stress disorder. Psychooncology. 2015;24(4):371–381. doi: 10.1002/pon.3654.
   PubMed Web of Science ®Google Scholar
• Arnaboldi P, Riva S, Crico C, et al. A systematic literature review exploring the prevalence of post-traumatic stress disorder and the role played by stress and traumatic stress in breast cancer diagnosis and trajectory. Breast Cancer. 2017;9:473–485. doi: 10.2147/BCTT.S111101.
   PubMed Web of Science ®Google Scholar
• Mehnert A, Koch U. Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: a prospective study. Psychooncology. 2007;16(3):181–188. doi: 10.1002/pon.1057.
   PubMed Web of Science ®Google Scholar
• Jacobsen PB, Widows MR, Hann DM, et al. Posttraumatic stress disorder symptoms after bone marrow transplantation for breast cancer. Psychosom Med. 1998;60(3):366–371. doi: 10.1097/00006842-199805000-00026.
   PubMed Web of Science ®Google Scholar
• Van Beek FE, Wijnhoven LMA, Custers JAE, et al. Adjustment disorder in cancer patients after treatment: prevalence and acceptance of psychological treatment. Support Care Cancer. 2022;30(2):1797–1806. doi: 10.1007/s00520-021-06530-0.
   PubMed Web of Science ®Google Scholar
• Tang H y, Xiong H h, Deng L C, et al. Adjustment disorder in female breast cancer patients: prevalence and its accessory symptoms. Curr Med Sci. 2020;40(3):510–517. doi: 10.1007/s11596-020-2205-1.
   PubMed Web of Science ®Google Scholar
• Miovic M, Block S. Psychiatric disorders in advanced cancer. Cancer. 2007;110(8):1665–1676. doi: 10.1002/cncr.22980.
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Haskard‐Zolnierek KB. Impact of depression on treatment adherence and survival from cancer. Depression and Cancer. 2011;101–124.
   Google Scholar
• Haskins CB, McDowell BD, Carnahan RM, et al. Impact of preexisting mental illness on breast cancer endocrine therapy adherence. Breast Cancer Res Treat. 2019;174(1):197–208. doi: 10.1007/s10549-018-5050-1.
   PubMed Web of Science ®Google Scholar
• Im A, Pavletic SZ. Immunotherapy in hematologic malignancies: past, present, and future. J Hematol Oncol. 2017;10(1):94. doi: 10.1186/s13045-017-0453-8.
   PubMed Web of Science ®Google Scholar
• Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med. 2010;363(22):2091–2101. doi: 10.1056/NEJMoa1004383.
   PubMed Web of Science ®Google Scholar
• Townsend W, Linch D. Hodgkin’s lymphoma in adults. Lancet. 2012;380(9844):836–847. doi: 10.1016/S0140-6736(12)60035-X.
   PubMed Web of Science ®Google Scholar
• Danylesko I, Shimoni A. Second malignancies after hematopoietic stem cell transplantation. Curr Treat Options Oncol. 2018;19(2):9. doi: 10.1007/s11864-018-0528-y.
   PubMed Web of Science ®Google Scholar
• Al Hamed R, Bazarbachi AH, Malard F, et al. Current status of autologous stem cell transplantation for multiple myeloma. Blood Cancer J. 2019;9(4):44. doi: 10.1038/s41408-019-0205-9.
   PubMedGoogle Scholar
• Loke J, Buka R, Craddock C. Allogeneic stem cell transplantation for acute myeloid leukemia: who, when, and how? Front Immunol. 2021;12:659595. doi: 10.3389/fimmu.2021.659595.
   PubMedGoogle Scholar
• Cho SY, Lee HJ, Lee DG. Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in korea. Korean J Intern Med. 2018;33(2):256–276. doi: 10.3904/kjim.2018.036.
   PubMed Web of Science ®Google Scholar
• Penack O, Marchetti M, Ruutu T, et al. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol. 2020;7(2):e157–67–e167. doi: 10.1016/S2352-3026(19)30256-X.
   Web of Science ®Google Scholar
• Kuba K, Esser P, Scherwath A, et al. Cancer-and-treatment-specific distress and its impact on posttraumatic stress in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT): cancer-and-treatment-specific distress following HSCT. Psychooncology. 2017;26(8):1164–1171. doi: 10.1002/pon.4295.
   PubMed Web of Science ®Google Scholar
• Jackson JC, Hart RP, Gordon SM, et al. Post-traumatic stress disorder and post-traumatic stress symptoms following critical illness in medical intensive care unit patients: assessing the magnitude of the problem. Crit Care. 2007;11(1):R27. doi: 10.1186/cc5707.
   PubMed Web of Science ®Google Scholar
• Krebber AMH, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: a meta‐analysis of diagnostic interviews and self‐report instruments. Psychooncology. 2014;23(2):121–130. doi: 10.1002/pon.3409.
   PubMed Web of Science ®Google Scholar
• Blevins CA, Weathers FW, Davis MT, et al. The posttraumatic stress disorder checklist for DSM-5 (PCL-5): development and initial psychometric evaluation. J Trauma Stress. 2015;28(6):489–498. doi: 10.1002/jts.22059.
   PubMed Web of Science ®Google Scholar
• Einsle F, Köllner V, Dannemann S, et al. Development and validation of a self-report for the assessment of adjustment disorders. Psychol Health Med. 2010;15(5):584–595. doi: 10.1080/13548506.2010.487107.
   PubMed Web of Science ®Google Scholar
• Jung A, Crandell JL, Nielsen ME, et al. Post-traumatic stress disorder symptoms in non-muscle-invasive bladder cancer survivors: a population-based study. Urol Oncol. 2021;39(4):237.e7-237–e14. doi: 10.1016/j.urolonc.2020.11.033.
   Web of Science ®Google Scholar
• Liang J, Lee SJ, Storer BE, et al. Rates and risk factors for post-traumatic stress disorder symptomatology among adult hematopoietic cell transplant recipients and their informal caregivers. Biol Blood Marrow Transplant. 2019;25(1):145–150. doi: 10.1016/j.bbmt.2018.08.002.
   PubMed Web of Science ®Google Scholar
• O'Connor M, Christensen S, Jensen AB, et al. How traumatic is breast cancer? Post-traumatic stress symptoms (PTSS) and risk factors for severe PTSS at 3 and 15 months after surgery in a nationwide cohort of danish women treated for primary breast cancer. Br J Cancer. 2011;104(3):419–426. doi: 10.1038/sj.bjc.6606073.
   PubMed Web of Science ®Google Scholar
• Smith SK, Zimmerman S, Williams CS, et al. Post-traumatic stress outcomes in non-Hodgkin’s lymphoma survivors. J Clin Oncol. 2008;26(6):934–941. doi: 10.1200/JCO.2007.12.3414.
   PubMed Web of Science ®Google Scholar
• Mosher CE, Redd WH, Rini CM, et al. Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology. 2009;18(2):113–127. doi: 10.1002/pon.1399.
   PubMed Web of Science ®Google Scholar
• Kangas M, Henry JL, Bryant RA. Posttraumatic stress disorder following cancer. Clin Psychol Rev. 2002;22(4):499–524. doi: 10.1016/s0272-7358(01)00118-0.
   PubMed Web of Science ®Google Scholar
• Esser P, Kuba K, Ernst J, et al. Trauma- and stressor-related disorders among hematological cancer patients with and without stem cell transplantation: protocol of an interview-based study according to updated diagnostic criteria. BMC Cancer. 2019;19(1):870. doi: 10.1186/s12885-019-6047-9.
   PubMed Web of Science ®Google Scholar
• Krüger-Gottschalk A, Knaevelsrud C, Rau H, et al. The german version of the posttraumatic stress disorder checklist for DSM-5 (PCL-5): psychometric properties and diagnostic utility. BMC Psychiatry. 2017;17(1):379. doi: 10.1186/s12888-017-1541-6.
   PubMed Web of Science ®Google Scholar
• McLaughlin KA, Koenen KC, Friedman MJ, et al. Subthreshold posttraumatic stress disorder in the world health organization world mental health surveys. Biol Psychiatry. 2015;77(4):375–384. doi: 10.1016/j.biopsych.2014.03.028.
   PubMed Web of Science ®Google Scholar
• Glaesmer H, Romppel M, Brähler E, et al. Adjustment disorder as proposed for ICD-11: dimensionality and symptom differentiation. Psychiatry Res. 2015;229(3):940–948. doi: 10.1016/j.psychres.2015.07.010.
   PubMed Web of Science ®Google Scholar
• Lorenz L, Bachem R, Maercker A. The adjustment disorder–new module 20 as a screening instrument: cluster analysis and cut-off values. Int J Occup Environ Med. 2016;7(4):215–220. doi: 10.15171/ijoem.2016.775.
   PubMed Web of Science ®Google Scholar
• Cohen J. A power primer. Psychol Bull. 1992;112(1):155–159. doi: 10.1037//0033-2909.112.1.155.
   PubMed Web of Science ®Google Scholar
• Varela VS, Ng A, Mauch P, et al. Posttraumatic stress disorder (PTSD) in survivors of Hodgkin’s lymphoma: prevalence of PTSD and partial PTSD compared with sibling controls: PTSD in survivors of Hodgkin’s lymphoma. Psychooncology. 2013;22(2):434–440. doi: 10.1002/pon.2109.
   PubMed Web of Science ®Google Scholar
• Liu L, Yang YL, Wang ZY, et al. Prevalence and positive correlates of posttraumatic stress disorder symptoms among chinese patients with hematological malignancies: a cross-sectional study. PLOS One. 2015;10(12):e0145103. doi: 10.1371/journal.pone.0145103.
   PubMed Web of Science ®Google Scholar
• O’Donnell ML, Agathos JA, Metcalf O, et al. Adjustment disorder: current developments and future directions. IJERPH. 2019;16(14):2537. doi: 10.3390/ijerph16142537.
   Web of Science ®Google Scholar
• Mundy EA, Blanchard EB, Cirenza E, et al. Posttraumatic stress disorder in breast cancer patients following autologous bone marrow transplantation or conventional cancer treatments. Behav Res Ther. 2000;38(10):1015–1027. doi: 10.1016/s0005-7967(99)00144-8.
   PubMed Web of Science ®Google Scholar
• Prieto JM, Blanch J, Atala J, et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol. 2002;20(7):1907–1917. doi: 10.1200/JCO.2002.07.101.
   PubMed Web of Science ®Google Scholar
• Mehnert A, Lehmann C, Graefen M, et al. Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients: depression and anxiety in prostate cancer. Eur J Cancer Care. 2010;19(6):736–745. doi: 10.1111/j.1365-2354.2009.01117.x.
   PubMed Web of Science ®Google Scholar
• Green BL, Rowland JH, Krupnick JL, et al. Prevalence of posttraumatic stress disorder in women with breast cancer. Psychosomatics. 1998;39(2):102–111. doi: 10.1016/S0033-3182(98)71356-8.
   PubMed Web of Science ®Google Scholar
• Jacobsen PB, Sadler IJ, Booth-Jones M, et al. Predictors of posttraumatic stress disorder symptomatology following bone marrow transplantation for cancer. J Consult Clin Psychol. 2002;70(1):235–240. doi: 10.1037//0022-006x.70.1.235.
   PubMed Web of Science ®Google Scholar
• Quinn G, Goncalves V, Sehovic I, et al. Quality of life in adolescent and young adult cancer patients: a systematic review of the literature. Patient Relat Outcome Meas. 2015;6:19–51. doi: 10.2147/PROM.S51658.
   PubMedGoogle Scholar
• Fenech AL, Van Benschoten O, Jagielo AD, et al. Post-Traumatic stress symptoms in hematopoietic stem cell transplant recipients. Transplant Cell Ther. 2021;27(4):341.e1–341.e6. doi: 10.1016/j.jtct.2021.01.011.
   PubMedGoogle Scholar